This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
If youre living with diabeteswhether prediabetes , Type 2 diabetes , or Type 1 diabetes then youre probably taking steps to manage your blood glucose levels. Along with regular exercise, sufficient sleep, and taking care of your mental health, following a healthy, balanced meal plan is one of the most effective components of diabetes management. As you focus on maintaining healthy blood sugar levels, being mindful of your carbohydrate intake is likely at the forefront of your mind.
For the second time in less than a year, the U.S. Federal Trade Commission released a highly critical report of pharmacy benefit managers, which play a crucial but opaque role in the pharmaceutical supply chain. And the findings may provide further impetus for legislative action to curb practices that critics say contribute to the rising cost of prescription drugs.
Pharmapack Europe: Basel the best location for drug device innovation in Europe thanks to combination of world class manufacturing and existing biomedical research infrastructure 18 December 2024 Paris, France New research released ahead of Pharmapack Europe the continents largest partnering event for medical device and packaging innovation has ranked the Basel region […] The post Switzerlands Basel Region Crowned Europes Top Destination to Launch a Drug Device Company, According to Ph
Top of the morning to you, and a fine one it is. Clear blue skies and chilly breezes are wafting across the Pharmalot campus, where the official mascots are snoozing after foraging for their breakfast. This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups of stimulation. Our choice today is maple bourbon, a necessary indulgence.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
New long-term data reveals that a modifier gene therapy delivered meaningful visual function improvements for retinitis pigmentosa participants in a Phase I/II clinical trial. A two-year safety and efficacy update from the OCU400 clinical trial showed that 100 percent of treated evaluable participants improved or preserved their visual function compared to untreated eyes at both one and two years.
Eli Lilly’s expectations for sales in the fourth quarter of last year missed forecasts, driven by lower-than-expected sales of its diabetes and obesity drugs Mounjaro and Zepbound. This is another notable stumble for the company after its third-quarter earnings report disappointed. In the fourth quarter, the pharma giant expects to have brought in $13.5 billion in revenue, less than the $13.9 billion that analysts polled by FactSet had forecast.
After years of prodding, the National Institutes of Health has adopted a new policy requiring companies seeking licenses to sell medical products invented with government research to submit plans for ensuring greater access to patients. Going forward, a company would not only have to submit an access plan when seeking to license the rights to sell a drug, vaccine or device, but would also have to update that plan as product development progresses.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. This is Matthew Herper. It was a little chillier in San Francisco this morning, and you can feel many JPM attendees dragging a bit from trying to pack a month into a day. It doesn’t help that, a day after J&J , Eli Lilly , and GSK all announced deals that gave some observers hope of a resurgence in M&A, Lilly, the mightiest drug company
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — but relies on more data.
The Federal Trade Commission released its second interim staff report on industry-leading pharmacy benefit managers and their practices specifically regarding specialty drugs.
The FTC released its second interim staff report Tuesday during Chair Lina Khan's final open commission meeting, but declined to indicate whether it would take further legal action.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The annual J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' biggest wheelers and dealers to San Francisco.
The pharmaceutical industry is facing a critical talent shortage caused by fewer students entering the field, burnout and a lack of stability. We offer ways to combat the shortage.
Chronic care management will continue to be an important growth driver for Teladoc, executives said. The company is teaming up with Amazon to make it easier for individuals to find and enroll in its virtual cardiometabolic programs.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! There are just two days left to submit nominations for our annual STAT Madness competition. It’s a bracket-style tournament honoring the best innovation in biomedical research, and a lot of fun.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The U.S. Supreme Court has agreed to hear a lawsuit that will determine whether preventive services will remain fully covered by group health plans under the Affordable Care Act (ACA). | The Supreme Court will decide the fate of the preventive services provision, a core component of the Affordable Care Act, by July.
In an interview at the J.P. Morgan Healthcare Conference on Tuesday, Morgan Health CEO Dan Mendelson told Fierce Healthcare that the firm's current portfolio of investments have focused on several key buckets within healthcare.
A ground-breaking New York Times investigation reveals how a for-profit federal contractor helps hospitals abuse the 340B program to charge huge markups on medicines. 340B has become a tool for profit, benefiting large hospital systems and private corporations far more than the patients it was designed to serve.
Cigna has tapped Progyny as it looks to enhance access to benefits for fertility and family planning services. | Cigna has tapped Progyny as it looks to enhance access to benefits for fertility and family planning services.
A series of uncertainties that kept dealmaking to a minimum last year could be reversing as pharma reloads pipelines ahead of the patent cliff explosion.
The Department of Health and Human Services released an AI Strategic Plan Jan. 10 that lays out short-term and long-term goals for ensuring AI is safe and trustworthy when deployed in healthcare. The plan emphasizes technical assistance for under-resourced organizations and workforce training initiatives.
Spotlighting innovation at the SCOPE Summit, finalists for the Site Innovation and Patient Engagement Awards showcase groundbreaking tools, AI solutions, and diversity-driven initiatives set to transform clinical trials.
At 2024s J.P. | Work to unify disparate programs has the $37 billion nonprofit system on an upward trajectory, CEO Wright Lassiter III told conference attendees.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content